In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...

Michael W. Schwartz explains the role played by the brain as a cause of elevated blood sugar and related metabolic ...

Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time ...

The Global Insulin Pump Market achieved a valuation of $5.90 Billion in 2024 and is anticipated to exceed $14.49 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 8.55% during the ...

Beck and colleagues from the JAEB Center for Health Research, Tampa, Florida, USA, highlight the rapid onset of action of inhaled Technosphere Insulin (TI, Afrezza) compare ...

New research reveals children of mothers with gestational diabetes face up to 32% higher risk of brain development issues.

Type 2 diabetes (T2D) is a complex and multifaceted disease that rarely exists in isolation. It is often entangled with a web of comorbid conditions, inclu | Immunology ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...